메뉴 건너뛰기




Volumn 14, Issue 6, 2013, Pages 362-369

No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010

Author keywords

CD4 cell decline; HIV; Viral set point; Virulence

Indexed keywords

ANTIRETROVIRUS AGENT;

EID: 84878917930     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12016     Document Type: Article
Times cited : (3)

References (28)
  • 2
    • 79960362331 scopus 로고    scopus 로고
    • The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study
    • Powers KA, Ghani AC, Miller WC etal. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 2011; 378: 256-268.
    • (2011) Lancet , vol.378 , pp. 256-268
    • Powers, K.A.1    Ghani, A.C.2    Miller, W.C.3
  • 3
    • 84858958596 scopus 로고    scopus 로고
    • No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial
    • Grijsen ML, Steingrover R, Wit FW etal. No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial. PLoS Med 2012; 9: e1001196.
    • (2012) PLoS Med , vol.9
    • Grijsen, M.L.1    Steingrover, R.2    Wit, F.W.3
  • 4
    • 84555189233 scopus 로고    scopus 로고
    • The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals
    • Hogan CM, Degruttola V, Sun X etal. The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. J Infect Dis 2012; 205: 87-96.
    • (2012) J Infect Dis , vol.205 , pp. 87-96
    • Hogan, C.M.1    Degruttola, V.2    Sun, X.3
  • 5
    • 79958755052 scopus 로고    scopus 로고
    • Adherence to national guidelines for initiation of antiretroviral regimens in HIV patients: a Danish nationwide study
    • Petersen TS, Andersen SE, Gerstoft J etal. Adherence to national guidelines for initiation of antiretroviral regimens in HIV patients: a Danish nationwide study. Br J Clin Pharmacol 2011; 72: 116-124.
    • (2011) Br J Clin Pharmacol , vol.72 , pp. 116-124
    • Petersen, T.S.1    Andersen, S.E.2    Gerstoft, J.3
  • 6
    • 70349853067 scopus 로고    scopus 로고
    • Cohort profile: the Danish HIV cohort study
    • Obel N, Engsig FN, Rasmussen LD etal. Cohort profile: the Danish HIV cohort study. Int J Epidemiol 2009; 38: 1202-1206.
    • (2009) Int J Epidemiol , vol.38 , pp. 1202-1206
    • Obel, N.1    Engsig, F.N.2    Rasmussen, L.D.3
  • 7
    • 84878926784 scopus 로고    scopus 로고
    • The Central Office of Civil Registration
    • (accessed 17 December 2011).
    • The Central Office of Civil Registration. The civil registration system in Denmark. 2011. Available at www.cpr.dk/cpr/site.aspx?p=34 (accessed 17 December 2011).
    • (2011) The civil registration system in Denmark
  • 8
    • 84155168018 scopus 로고    scopus 로고
    • Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission
    • Herbeck JT, Muller V, Maust BS etal. Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission. AIDS 2012; 26: 193-205.
    • (2012) AIDS , vol.26 , pp. 193-205
    • Herbeck, J.T.1    Muller, V.2    Maust, B.S.3
  • 9
    • 33646706853 scopus 로고    scopus 로고
    • Stable virulence levels in the HIV epidemic of Switzerland over two decades
    • Muller V, Ledergerber B, Perrin L etal. Stable virulence levels in the HIV epidemic of Switzerland over two decades. AIDS 2006; 20: 889-894.
    • (2006) AIDS , vol.20 , pp. 889-894
    • Muller, V.1    Ledergerber, B.2    Perrin, L.3
  • 10
    • 45249105776 scopus 로고    scopus 로고
    • Lack of evidence for changing virulence of HIV-1 in North America
    • Herbeck JT, Gottlieb GS, Li X etal. Lack of evidence for changing virulence of HIV-1 in North America. PLoS ONE 2008; 3: e1525.
    • (2008) PLoS ONE , vol.3
    • Herbeck, J.T.1    Gottlieb, G.S.2    Li, X.3
  • 11
    • 67651119957 scopus 로고    scopus 로고
    • No evidence of a change in HIV-1 virulence since 1996 in France
    • Troude P, Chaix ML, Tran L etal. No evidence of a change in HIV-1 virulence since 1996 in France. AIDS 2009; 23: 1261-1267.
    • (2009) AIDS , vol.23 , pp. 1261-1267
    • Troude, P.1    Chaix, M.L.2    Tran, L.3
  • 12
    • 67249156626 scopus 로고    scopus 로고
    • Increasing clinical virulence in two decades of the Italian HIV epidemic
    • Muller V, Maggiolo F, Suter F etal. Increasing clinical virulence in two decades of the Italian HIV epidemic. PLoS Pathog 2009; 5: e1000454.
    • (2009) PLoS Pathog , vol.5
    • Muller, V.1    Maggiolo, F.2    Suter, F.3
  • 13
    • 33846794933 scopus 로고    scopus 로고
    • Temporal trends in postseroconversion CD4 cell count and HIV load: the concerted action on seroconversion to AIDS and death in Europe collaboration, 1985-2002
    • Dorrucci M, Rezza G, Porter K, Phillips A. Temporal trends in postseroconversion CD4 cell count and HIV load: the concerted action on seroconversion to AIDS and death in Europe collaboration, 1985-2002. J Infect Dis 2007; 195: 525-534.
    • (2007) J Infect Dis , vol.195 , pp. 525-534
    • Dorrucci, M.1    Rezza, G.2    Porter, K.3    Phillips, A.4
  • 14
    • 9844247552 scopus 로고    scopus 로고
    • Has the rate of progression to AIDS changed in recent years?
    • Carre N, Prins M, Meyer L etal. Has the rate of progression to AIDS changed in recent years? AIDS 1997; 11: 1611-1618.
    • (1997) AIDS , vol.11 , pp. 1611-1618
    • Carre, N.1    Prins, M.2    Meyer, L.3
  • 15
    • 0001507107 scopus 로고    scopus 로고
    • Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on Seroconversion to AIDS and Death in Europe
    • CASCADE
    • CASCADE. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on Seroconversion to AIDS and Death in Europe. Lancet 2000; 355: 1131-1137.
    • (2000) Lancet , vol.355 , pp. 1131-1137
  • 17
    • 82455163716 scopus 로고    scopus 로고
    • Molecular phylogenetics of transmitted drug resistance in newly diagnosed HIV Type 1 individuals in Denmark: a nation-wide study
    • Audelin AM, Gerstoft J, Obel N etal. Molecular phylogenetics of transmitted drug resistance in newly diagnosed HIV Type 1 individuals in Denmark: a nation-wide study. AIDS Res Hum Retroviruses 2011; 27: 1283-1290.
    • (2011) AIDS Res Hum Retroviruses , vol.27 , pp. 1283-1290
    • Audelin, A.M.1    Gerstoft, J.2    Obel, N.3
  • 18
    • 0025950082 scopus 로고
    • More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts
    • Phillips AN, Lee CA, Elford J etal. More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts. J Acquir Immune Defic Syndr 1991; 4: 970-975.
    • (1991) J Acquir Immune Defic Syndr , vol.4 , pp. 970-975
    • Phillips, A.N.1    Lee, C.A.2    Elford, J.3
  • 19
    • 77955429229 scopus 로고    scopus 로고
    • HIV transmission and high rates of late diagnoses among adults aged 50 years and over
    • Smith RD, Delpech VC, Brown AE, Rice BD. HIV transmission and high rates of late diagnoses among adults aged 50 years and over. AIDS 2010; 24: 2109-2115.
    • (2010) AIDS , vol.24 , pp. 2109-2115
    • Smith, R.D.1    Delpech, V.C.2    Brown, A.E.3    Rice, B.D.4
  • 20
    • 80052892986 scopus 로고    scopus 로고
    • Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm(3): assessment of need following changes in treatment guidelines
    • Lodi S, Phillips A, Touloumi G etal. Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm(3): assessment of need following changes in treatment guidelines. Clin Infect Dis 2011; 53: 817-825.
    • (2011) Clin Infect Dis , vol.53 , pp. 817-825
    • Lodi, S.1    Phillips, A.2    Touloumi, G.3
  • 21
    • 80051633217 scopus 로고    scopus 로고
    • Prevention of HIV-1 infection with early antiretroviral therapy
    • Cohen MS, Chen YQ, McCauley M etal. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493-505.
    • (2011) N Engl J Med , vol.365 , pp. 493-505
    • Cohen, M.S.1    Chen, Y.Q.2    McCauley, M.3
  • 22
    • 84862215127 scopus 로고    scopus 로고
    • CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE
    • Young J, Psichogiou M, Meyer L etal. CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med 2012; 9: e1001194.
    • (2012) PLoS Med , vol.9
    • Young, J.1    Psichogiou, M.2    Meyer, L.3
  • 23
    • 79956187631 scopus 로고    scopus 로고
    • Incidence of non-AIDS-defining cancer in antiretroviral treatment-naive subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis
    • Krishnan S, Schouten JT, Jacobson DL etal. Incidence of non-AIDS-defining cancer in antiretroviral treatment-naive subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis. Oncology 2011; 80: 42-49.
    • (2011) Oncology , vol.80 , pp. 42-49
    • Krishnan, S.1    Schouten, J.T.2    Jacobson, D.L.3
  • 24
    • 79958104634 scopus 로고    scopus 로고
    • Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy
    • Kesselring A, Gras L, Smit C etal. Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. Clin Infect Dis 2011; 52: 1458-1465.
    • (2011) Clin Infect Dis , vol.52 , pp. 1458-1465
    • Kesselring, A.1    Gras, L.2    Smit, C.3
  • 25
    • 84859636864 scopus 로고    scopus 로고
    • All-cause mortality in treated HIV-infected adults with CD4>/=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration
    • Lewden C, Bouteloup V, De WS etal. All-cause mortality in treated HIV-infected adults with CD4>/=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol 2012; 41: 433-445.
    • (2012) Int J Epidemiol , vol.41 , pp. 433-445
    • Lewden, C.1    Bouteloup, V.2    De, W.S.3
  • 26
    • 84864131448 scopus 로고    scopus 로고
    • Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel
    • Thompson MA, Aberg JA, Hoy JF etal. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 2012; 308: 387-402.
    • (2012) JAMA , vol.308 , pp. 387-402
    • Thompson, M.A.1    Aberg, J.A.2    Hoy, J.F.3
  • 27
    • 84859107011 scopus 로고    scopus 로고
    • Retention in a public health care system with free access to treatment: a Danish nationwide HIV cohort study
    • Helleberg M, Engsig FN, Kronborg G etal. Retention in a public health care system with free access to treatment: a Danish nationwide HIV cohort study. AIDS 2012; 26: 741-748.
    • (2012) AIDS , vol.26 , pp. 741-748
    • Helleberg, M.1    Engsig, F.N.2    Kronborg, G.3
  • 28
    • 84858995372 scopus 로고    scopus 로고
    • Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort
    • Helleberg M, Engsig FN, Kronborg G etal. Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort. Scand J Infect Dis 2012; 44: 282-288.
    • (2012) Scand J Infect Dis , vol.44 , pp. 282-288
    • Helleberg, M.1    Engsig, F.N.2    Kronborg, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.